In this episode of the Navigating Risk podcast, we delve into the obstacles that high-growth businesses encounter within heavily regulated sectors such as life sciences.
null

In this episode our host Helen Yates, Editor of Global Thought Leadership, talks to Mo Khan. Mo is the Chief Executive Officer of hVIVO with over 25 years of experience in clinical research and the contract research organisation (CRO) industry and shares his thoughts on the challenges facing a high-growth business in a highly regulated sector.

Listen to Mo and Helen discuss some of the challenges that they have been facing in the UK in recent years.

Insights

Helen Yates: Hello and welcome to the Navigating Risk podcast. My name is Helen Yates, I’m Gallagher’s Editor of Global Thought Leadership. I’m joined today by Mo Khan, Chief Executive of hVIVO, a Life Science firm that specialises in human challenge clinical trials out of their new facilities in London’s Canary Wharf. Do you want to start by telling us a little bit about yourself?

Yamin ‘Mo’ Khan: Hi, I’m Yamin Mo Khan, I’m the CEO of hVIVO. I have a PhD in biochemistry and I took my first career in the clinical research industry back in 1996, which seems like a lifetime away, to be honest with you. Then I worked for a number of different contract research organisations or CROs if you will, including some of the biggest CROs in the word, but my main experience was with the CRO Pharm-Olam which we built from a small CRO to a mid-size global CRO, which we then sold to a private equity firm.

After that I took some time out and joined what was then called Open Orphan in October 2021 as a non-executive director and I took on the CEO role in February 2022 and then we rebranded the company to hVIVO and I’ve been there ever since.

You can find out more about Mo’s thoughts about the challenges facing a high-growth business by listening to the full episode of our Navigating Risk podcast. Keep an eye out for the next Navigating Risk discussion.

Disclaimer

Gallagher is a risk management, insurance and HR/benefits consultancy and will be sharing their views in that capacity. This podcast is not intended to give legal or financial advice, and, accordingly, should not be relied upon for such. This should not be regarded as a comprehensive statement of the law and/or market practice in this area. In preparing this webinar we have relied on information sourced from third parties and we make no claims as to the completeness or accuracy of the information contained herein. You should not act upon information nor determine not to act, without first seeking specific specialist advice. Our advice to our clients is as an insurance broker and is provided subject to specific terms and conditions, the terms of which take precedence over any representations in this webinar. No third party to whom this is passed can rely on it. We and our officers, employees or agents shall not be responsible for any loss whatsoever arising from the recipient’s reliance upon any information we provide herein and exclude liability for the content to fullest extent permitted by law. Should you require advice about your specific arrangements or circumstances, please get in touch with Gallagher.